Valuation DBV Technologies Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 02:01:08 2026-09-04 EDT			5-day change	1st Jan Change
2.306 ^EUR	+0.17%		-4.24%	-29.05%

09-04	European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading	MT
09-01	European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	168.2	295.6	178	64.61	678.1	682.4	-	-
Change	-	75.76%	-39.8%	-63.7%	949.56%	0.63%	-	-
Enterprise Value (EV) ¹	98.88	98.35	48.63	35.95	509.7	606.9	659.7	639.8
Change	-	-0.54%	-50.56%	-26.07%	1,318.01%	19.06%	8.69%	-3.02%
P/E	-0.94x	-1.35x	-1.33x	-1.15x	-7.43x	-5.24x	-16.1x	17.3x
PBR	0.94x	0.81x	0.69x	-	10.9x	9.9x	22.8x	6.76x
PEG	-	0x	0x	0x	0.4x	1.55x	0.2x	-0x
Capitalization / Revenue	32.6x	65.3x	12.4x	16.6x	139x	266x	9.72x	2.8x
EV / Revenue	19.1x	21.7x	3.38x	9.26x	104x	237x	9.39x	2.63x
EV / EBITDA	-1.2x	-1.25x	-0.59x	-	-4.09x	-3.82x	-12.9x	11.8x
EV / EBIT	-1.1x	-1.08x	-0.7x	-0.33x	-4x	-3.43x	-5.48x	38x
EV / FCF	-1.01x	-1.85x	-1.03x	-0.38x	-4.83x	-2.29x	-2.72x	36.6x
FCF Yield	-99.1%	-54.1%	-97.5%	-262%	-20.7%	-43.6%	-36.7%	2.73%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.24	-2.339	-1.391	-0.546	-0.4552	-0.4398	-0.143	0.133
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	5.165	4.526	14.39	3.883	4.886	2.561	70.24	243.4
EBITDA ¹	-82.28	-78.71	-82.74	-	-124.7	-158.7	-51.22	54.32
EBIT ¹	-89.75	-90.72	-69.94	-107.7	-127.5	-177.1	-120.4	16.82
Net income ¹	-144.5	-90.53	-66.54	-105.5	-127.4	-174.1	-116	7.006
Net Debt ¹	-69.31	-197.3	-129.4	-28.66	-168.3	-75.46	-22.7	-42.61
Reference price ²	3.059	3.146	1.849	0.630	3.380	2.306	2.306	2.306
Nbr of stocks (in thousands)	54,983	93,967	96,256	102,550	200,618	295,915	-	-
Announcement Date	3/3/22	3/2/23	3/7/24	3/24/25	3/26/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK & CO., INC.	109.49x	6.09x	25.83x	2.27%	371B
MERCK KGAA	23x	3.11x	10.87x	1.73%	68.64B
HALOZYME THERAPEUTICS, INC.	15.29x	7.47x	11.45x	-	12.51B
KYOWA KIRIN CO., LTD.	15.34x	1.94x	6.58x	2.89%	8.06B
SK BIOPHARMACEUTICALS CO., LTD.	20.56x	6.44x	17.14x	-.--%	5.04B
YUHAN CORPORATION	40.87x	2.56x	29.23x	0.7%	4.51B
BETTA PHARMACEUTICALS CO., LTD.	35.24x	5.51x	16.13x	-	3.07B
SUPERNUS PHARMACEUTICALS, INC.	-217.65x	-	-	-.--%	2.53B
Average	5.27x	4.73x	16.75x	1.26%	59.41B
Weighted average by Cap.	89.10x	5.59x	22.83x	2.15%